Kane Biotech Inc V.KNE

It's moving...

[francoisl13]

We finally had apositive trading week with good volume, it bodes well for the coming weeks.
I'm still a little disappointed by the fact that they claim in their website presentation that FDA approval will come in Q1 2023 but, Dr Schultz and Mr. Edwards are telling the press that it will be Q2. That means that commercialization will be later than previously announced (ie.:Q1 2023). It also means that their message is not well aligned.
Well, I guess that we will all forget that when FDA approval happens :)
GLTA

[pibopibopibopib]

Oui mais le temps de recevoir une rponse de la FDA ne peut qu'tre approximatif de toute faon.  J'ai acheter un peu cette semaine et j'aimerais en ajouter une couche supplmentaire. Faudrait pas que amonte trop.

[francoisl13]

Boy oh boy, the FDA is taking sooooooooooooo long to approve Coactiv+....well, I guess that Dr. Schultz knew better than our ceo about the approval process....it will be Q2 (or later...). So, in short, commercialization will come later than expected (or promised) and it is clear that their message is not aligned - kind of surprising for such a small company. It would be nice to get an update

[RoyMax123]

Well, for the BOD you have your answer here, no other directors to vote for at the annual meeting.  https://ceo.ca/content/sedar/KNE-20230502-Management-information-circular-English-780e.pdf